Literature DB >> 18465141

Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor.

Parvin Mehdipour1, Laleh Habibi, Javad Mohammadi-Asl, Naser Kamalian, Masoud Mehr Azin.   

Abstract

Ataxia telangictasia mutated (ATM) is involved in DNA repair pathway and cell-cycle checkpoints. ATM alterations were found in medulloblastomas, gliomas, but not in astrocytoma. The polymorphism D1853N was reported in healthy individuals and medulloblastomas. We could observe this polymorphism, heterozygously, in a proband affected with astrocytoma and traced it through her pedigree. We propose the three-hit hypothesis as a triangle initiators includes D1853N as a first predisposing hit, IVS 38- 63T --> A as a second hit deriving from the first somatic evolution before differentiation and IVS 38- 30 A --> G as a third hit through the development of an astrocytoma. In addition, the D1853N polymorphism was occurred in different allele from IVS 38- 63T --> A and IVS 38- 30 A --> G.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465141     DOI: 10.1007/s00432-008-0404-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  Global analysis of ATM polymorphism reveals significant functional constraint.

Authors:  Y R Thorstenson; P Shen; V G Tusher; T L Wayne; R W Davis; G Chu; P J Oefner
Journal:  Am J Hum Genet       Date:  2001-07-03       Impact factor: 11.025

2.  Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia.

Authors:  W L Bigbee; R G Langlois; M Swift; R H Jensen
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-1987. A 30-year-old man with ataxia-telangiectasia and dysphagia.

Authors: 
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

Review 4.  Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis.

Authors:  R A Gatti; E Boder; H V Vinters; R S Sparkes; A Norman; K Lange
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

5.  Helper and suppressor t-lymphocyte leukemia in ataxia telangiectasia.

Authors:  A Saxon; R H Stevens; D W Golde
Journal:  N Engl J Med       Date:  1979-03-29       Impact factor: 91.245

6.  ATM gene mutations are not involved in medulloblastoma in children.

Authors:  Ella Liberzon; Smadar Avigad; Ian J Cohen; Isaac Yaniv; Shalom Michovitz; Rina Zaizov
Journal:  Cancer Genet Cytogenet       Date:  2003-10-15

7.  Characterization of ATM gene mutations in 66 ataxia telangiectasia families.

Authors:  N Sandoval; M Platzer; A Rosenthal; T Dörk; R Bendix; B Skawran; M Stuhrmann; R D Wegner; K Sperling; S Banin; Y Shiloh; A Baumer; U Bernthaler; H Sennefelder; M Brohm; B H Weber; D Schindler
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

8.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

Authors:  S Matsuoka; M Huang; S J Elledge
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more
  8 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.

Authors:  Parvin Mehdipour; Marzieh Mahdavi; Javad Mohammadi-Asl; Morteza Atri
Journal:  Med Oncol       Date:  2010-04-16       Impact factor: 3.064

3.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

4.  Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehr-Azin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-01-14       Impact factor: 3.064

Review 5.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

6.  ATM in breast and brain tumors: a comprehensive review.

Authors:  Mehrdad Asghari Estiar; Parvin Mehdipour
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

7.  Diversity in tumor territory of meningioma: Protein expression in vascular endothelial growth factor and epidermal growth factor.

Authors:  Parvin Mehdipour; Firoozeh Javan; Morteza Faghih-Jouibari; Mehdi Khaleghi
Journal:  Iran J Neurol       Date:  2019-04-04

8.  Evolutionary model of brain tumor circulating cells: Cellular galaxy.

Authors:  Parvin Mehdipour; Firoozeh Javan; Morteza Faghih Jouibari; Mehdi Khaleghi; Masoud Mehrazin
Journal:  World J Clin Oncol       Date:  2021-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.